期刊文献+

复方苦参注射液联合FOLFOX方案治疗结肠癌的疗效观察 被引量:8

Observation on the curative effect of compound matrine injection combined with FOLFOX regimen in the treatment of colon cancer
下载PDF
导出
摘要 目的:探讨复方苦参注射液联合FOLFOX方案治疗结肠癌的价值和意义。方法:按照随机数字表的方法选取结肠癌患者100例,按照双盲对照的原则分为试验组和对照组各50例,所有患者均采取FOLFOX方案化疗,试验组同时给予复方苦参注射用治疗,比较不同治疗方案的疗效差异。结果:试验组和对照组均获得临床疗效,但是试验组总缓解率更显著,两组比较,差异有统计学意义(P<0.05)。结论:复方苦参注射液联合FOLFOX方案治疗结肠癌能够明显提高患者的治疗效果,延长其生存期,安全性高。 Objective:To explore the value and significance of compound matrine injection combined with FOLFOX regimen in the treatment of colon cancer.Methods:100 patients with colon cancer were selected according to the random number table method,and they were divided in into the experimental group and the control group accordance with the principle of double blind,with 50 cases in each group.All the patients were treated with FOLFOX chemotherapy,while patients in the experimental group were also given compound matrine injection,then we compared the differences in efficacy between groups.Results:Both the experimental group and the control group were obtained the clinical curative effect,but the total remission rate of the experimental group was more significant,and the difference between groups was statistically significant(P<0.05).Conclusion:Compound matrine injection combined with FOLFOX regimen in the treatment of colon cancer can improve the patient's treatment effect significantly,prolong the survival time and high safety.
作者 蒋丽华 Jiang Lihua(The People's Hospital of Linyi Economic and Technological Development Zone,276000)
出处 《中国社区医师》 2016年第10期103-104,共2页 Chinese Community Doctors
关键词 结肠癌 复方苦参注射用 FOLFOX方案 Colon cancer Compound matrine injection FOLFOX scheme
  • 相关文献

参考文献5

二级参考文献20

  • 1刘俊杰,周成运.苦参素注射液治疗56例肿瘤化疗后白细胞减少症[J].肿瘤学杂志,2005,11(2):155-156. 被引量:16
  • 2陈曦,陈樟树,欧阳学农,陈雄.紫杉醇联合草酸铂治疗晚期胃癌的临床观察[J].临床肿瘤学杂志,2006,11(9):711-712. 被引量:1
  • 3Burris Ha, Moore MJ,Anderson J, et al. Improvements in survival and clinical benefit with gemcitabine as first - line therapy for patients with advanced pancreas cancer:a randomized trial [J]. J Clin Oncol, 1997,15:2403.
  • 4Ohtsu A ,Shirao K,Miyata Y ,et al. A phase Ⅱ study of three- hour infusion paclitaxel in patients with advanced gastric cancer [J]. Proceeding of Asco,2000,19:303a.
  • 5周际昌.实用肿瘤内科学[M]北京:人民卫生出版社,200347-48.
  • 6Jeung HC,Rha SY,Shin SJ. Two dosages of oral fluoropyrimidine S-1 of 35 and 40 mg/m2 bid:comparison of the pharmacokinetic profiles in Korean patients with advanced gastric cancer[J].Japanese Journal of Clinical Oncology,2010,(01):29-35.
  • 7孙燕;周际昌.临床肿瘤内科手册[M]北京:人民卫生出版社,2003102-150.
  • 8Hironaka S,Yamazaki K,Taku K. Phase I study of docetaxel,cisplatin and S-1 in patients with advanced gastric cancer[J].Japanese Journal of Clinical Oncology,2010,(11):1014-1020.
  • 9熊良庚.岩舒联合化疗治疗晚期胃癌的临床观察[J].实用癌症杂志,2008,23(3):276-277. 被引量:13
  • 10王建文,孙娟.复方苦参注射液治疗Ⅳ期非小细胞肺癌60例[J].肿瘤研究与临床,2009,21(6):413-414. 被引量:4

共引文献59

同被引文献157

引证文献8

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部